NIVI Research Center welcomes Henrik Nyhus Kløverpris

Henrik Nyhus Kløverpris has joined the Airway Immunity research group as Co-Principal Investigator. He will focus on high-resolution profiling of the respiratory mucosal immunity in vaccine responses.

Henrik Nyhus Kløverpris is an Associate Professor of Immunology at the Department of Immunology and Microbiology (ISIM), University of Copenhagen, and now he will be sharing his time between ISIM and NIVI Research Center.

He has been studying mucosal immunity for more than a decade, starting with a Sapere Aude grant for a 4-year postdoc. His research took him to South Africa, at the Africa Health Research Institute (AHRI), where he as a faculty member at AHRI studies gut barrier immunity in tissue samples from people living with HIV providing insights into how HIV affects mucosal immunity and how new treatments are required to restore gut homeostasis to reduce chronic inflammation.

During the COVID-19 pandemic, Henrik Nyhus Kløverpris continued his work in South Africa, investigating what happened to gut barrier immunity in HIV patients during a coronavirus infection.

Currently, he is part of the Danish project VAXXAIR, studying differences in mucosal immune responses to influenza vaccines administered via nasal spray or shoulder injection.

At NIVI Research Center, he will continue to explore respiratory mucosal immunity. His goal is to establish a platform for measuring respiratory immune responses to understand how immune and tissue cells communicate in response to vaccines and/or human viral infections at the single-cell level.

"I find it an incredibly exciting opportunity - both to advance the understanding of mucosal immunity and to be part of a local development where I can build new research collaborations and contribute with existing networks, including in South Africa and the USA, working on respiratory infections", he says.